Denali Therapeutics
DNLI
#3480
Rank
โ‚ฌ3.72 B
Marketcap
23,46ย โ‚ฌ
Share price
0.64%
Change (1 day)
92.09%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2025 (TTM): -2,58ย โ‚ฌ

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,59ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,25ย โ‚ฌ a decrease over its 2023 EPS that were of -0,91ย โ‚ฌ.

EPS history for Denali Therapeutics from 2017 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,58ย โ‚ฌ15.08%
2024-2,25ย โ‚ฌ147.12%
2023-0,91ย โ‚ฌ-60%
2022-2,27ย โ‚ฌ8.79%
2021-2,09ย โ‚ฌ-712.82%
20200,34ย โ‚ฌ-118.93%
2019-1,80ย โ‚ฌ402.44%
2018-0,36ย โ‚ฌ-88.89%
2017-3,22ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Organovo
ONVO
-10,06ย โ‚ฌ 287.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-6,20ย โ‚ฌ 139.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
2,39ย โ‚ฌ-192.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-1,34ย โ‚ฌ-48.48% Jersey